4536 Santen Pharmaceutical
- 1846.5
- +39.0+2.16%
Santen Pharmaceutical News
Santen Pharmaceutical: Corporate Governance Report 07/01/2024
Santen Pharmaceutical: Internal Control Report - 112 (2023/04/01 - 2024/03/31)
Santen Pharmaceutical: financial statements
Santen Pharmaceutical: business report
Santen Pharmaceutical: Notice of the 2024 Convocation Annual General Meeting
Santen Pharmaceutical: Partial amendments to the convocation notice
Santen Pharmaceutical: 2024 Annual General Meeting of Shareholders Convocation Notice and Shareholders' Meeting Materials
Santen Pharmaceutical: 2024 Annual General Meeting of Shareholders Convocation Notice and Shareholders' Meeting Materials
Santen Pharmaceutical: Notice regarding change of representative director
Santen Pharmaceutical: Report on Corporate Governance 2023/12/27
Santen Pharmaceutical: Report on Corporate Governance 2023/07/03
Santen Pharmaceutical: Internal Control Report - 111th Period (2022/04/01 - 2023/03/31)
Santen Pharmaceutical: Notice of Convocation Annual General Meeting 2023
Santen Pharmaceutical: 2023 Annual General Meeting of Shareholders Materials and Other Measures for Electronic Provision
Santen Pharmaceutical: Notice of Convocation of the 2023 Annual General Meeting of Shareholders
Santen Pharmaceutical Co Ltd: Report on corporate governance 2022-09-15
Santen Pharmaceutical Co Ltd: Notice on the transfer (resignation) of the chairman and the replacement of the general manager
Santen Pharmaceutical Co Ltd: Report on corporate governance 2022-06-29
Santen Pharmaceutical Co Ltd: Internal Control report-No. 110 (order and 1 April 3-order and 31 March 4)
Santen Pharmaceutical Co Ltd: The annual general meeting of shareholders in 2022 was convened to inform the Internet of the disclosure.
Analysis
Price Target
No Data
